Lista de obras - Miriam Molina-Arcas - Dominio Público Uruguay

3'-Azido-2',3'-dideoxythymidine (zidovudine) uptake mechanisms in T lymphocytes.

artículo científico publicado en 2006

A splice variant of the SLC28A3 gene encodes a novel human concentrative nucleoside transporter-3 (hCNT3) protein localized in the endoplasmic reticulum.

artículo científico publicado en 2008

Aquaporin 3 (AQP3) participates in the cytotoxic response to nucleoside-derived drugs

artículo científico publicado en 2012

Cell entry and export of nucleoside analogues

artículo científico publicado en 2005

Compensatory effects of the human nucleoside transporters on the response to nucleoside-derived drugs in breast cancer MCF7 cells.

artículo científico publicado en 2007

Complex regulation of nucleoside transporter expression in epithelial and immune system cells

artículo científico publicado en 2001

Coordinate direct input of both KRAS and IGF1 receptor to activation of PI3 kinase in KRAS-mutant lung cancer

artículo científico publicado en 2013

Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies

artículo científico publicado en 2012

Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer

artículo científico publicado en 2019

Equilibrative nucleoside transporter-2 (hENT2) protein expression correlates with ex vivo sensitivity to fludarabine in chronic lymphocytic leukemia (CLL) cells

artículo científico publicado en 2005

Expression and functionality of anti-human immunodeficiency virus and anticancer drug uptake transporters in immune cells

artículo científico publicado en 2007

Expression of human equilibrative nucleoside transporter 1 (hENT1) and its correlation with gemcitabine uptake and cytotoxicity in mantle cell lymphoma.

artículo científico publicado en 2006

Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia

artículo científico publicado en 2003

How to Fool a Wonder Drug: Truncate and Dimerize

Human equilibrative nucleoside transporter-1 (hENT1) is required for the transcriptomic response of the nucleoside-derived drug 5'-DFUR in breast cancer MCF7 cells.

artículo científico publicado en 2006

Hypoxia and P1 receptor activation regulate the high-affinity concentrative adenosine transporter CNT2 in differentiated neuronal PC12 cells

artículo científico publicado en 2013

Identification of TIGAR in the equilibrative nucleoside transporter 2-mediated response to fludarabine in chronic lymphocytic leukemia cells

artículo científico publicado en 2008

Interaction of nucleoside inhibitors of HIV-1 reverse transcriptase with the concentrative nucleoside transporter-1 (SLC28A1).

artículo científico publicado en 2004

Nucleoside transporter profiles in human pancreatic cancer cells: role of hCNT1 in 2',2'-difluorodeoxycytidine- induced cytotoxicity.

artículo científico publicado en 2003

Nucleoside transporter proteins

artículo científico publicado en 2009

Nucleoside transporters in chronic lymphocytic leukaemia

artículo científico publicado en 2004

Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA.

artículo científico publicado en 2017

Physiological and pharmacological roles of nucleoside transporter proteins

artículo científico publicado en 2008

RAC1P29S Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy Resistance

scientific article published on 27 June 2019

RAS signalling through PI3-Kinase controls cell migration via modulation of Reelin expression

artículo científico publicado en 2016

Role of nucleoside transporters in nucleoside-derived drug sensitivity

artículo científico publicado en 2010

SHOC2 phosphatase-dependent RAF dimerization mediates resistance to MEK inhibition in RAS-mutant cancers

scientific article published on 10 June 2019

The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer

artículo científico publicado en 2012

The human concentrative nucleoside transporter-3 C602R variant shows impaired sorting to lipid rafts and altered specificity for nucleoside-derived drugs

artículo científico

Transport of lamivudine [(-)-beta-L-2',3'-dideoxy-3'-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3

scientific journal article

Lista de obras de Miriam Molina-Arcas

3'-Azido-2',3'-dideoxythymidine (zidovudine) uptake mechanisms in T lymphocytes.

A splice variant of the SLC28A3 gene encodes a novel human concentrative nucleoside transporter-3 (hCNT3) protein localized in the endoplasmic reticulum.

Aquaporin 3 (AQP3) participates in the cytotoxic response to nucleoside-derived drugs

Cell entry and export of nucleoside analogues

Compensatory effects of the human nucleoside transporters on the response to nucleoside-derived drugs in breast cancer MCF7 cells.

Complex regulation of nucleoside transporter expression in epithelial and immune system cells

Coordinate direct input of both KRAS and IGF1 receptor to activation of PI3 kinase in KRAS-mutant lung cancer

Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies

Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer

Equilibrative nucleoside transporter-2 (hENT2) protein expression correlates with ex vivo sensitivity to fludarabine in chronic lymphocytic leukemia (CLL) cells

Expression and functionality of anti-human immunodeficiency virus and anticancer drug uptake transporters in immune cells

Expression of human equilibrative nucleoside transporter 1 (hENT1) and its correlation with gemcitabine uptake and cytotoxicity in mantle cell lymphoma.

Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia

How to Fool a Wonder Drug: Truncate and Dimerize

Human equilibrative nucleoside transporter-1 (hENT1) is required for the transcriptomic response of the nucleoside-derived drug 5'-DFUR in breast cancer MCF7 cells.

Hypoxia and P1 receptor activation regulate the high-affinity concentrative adenosine transporter CNT2 in differentiated neuronal PC12 cells

Identification of TIGAR in the equilibrative nucleoside transporter 2-mediated response to fludarabine in chronic lymphocytic leukemia cells

Interaction of nucleoside inhibitors of HIV-1 reverse transcriptase with the concentrative nucleoside transporter-1 (SLC28A1).

Nucleoside transporter profiles in human pancreatic cancer cells: role of hCNT1 in 2',2'-difluorodeoxycytidine- induced cytotoxicity.

Nucleoside transporter proteins

Nucleoside transporters in chronic lymphocytic leukaemia

Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA.

Physiological and pharmacological roles of nucleoside transporter proteins

RAC1P29S Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy Resistance

RAS signalling through PI3-Kinase controls cell migration via modulation of Reelin expression

Role of nucleoside transporters in nucleoside-derived drug sensitivity

SHOC2 phosphatase-dependent RAF dimerization mediates resistance to MEK inhibition in RAS-mutant cancers

The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer

The human concentrative nucleoside transporter-3 C602R variant shows impaired sorting to lipid rafts and altered specificity for nucleoside-derived drugs

Transport of lamivudine [(-)-beta-L-2',3'-dideoxy-3'-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3